FDA Import Refusal SCS-1618649-8/11/1 — ASTRAZENECA PHARMA INDIA LTD
The FDA refused shipment SCS-1618649-8/11/1 from ASTRAZENECA PHARMA INDIA LTD (India) on Sep 9, 2020. The refused product falls under Drugs and Biologics — TAMOXIFEN CITRATE (ANTI-ESTROGEN). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 9, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61UCY05 TAMOXIFEN CITRATE (ANTI-ESTROGEN)
- Charges
- 75